Portfolio company
AI VIVO
United Kingdom
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
2 investors
Sectors
About
This systems pharmacology company provides an artificial intelligence platform to accelerate drug discovery and predict clinical efficacy for global pharmaceutical partners.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
VeriSIM Life
The company develops an artificial intelligence platform to simulate drug candidate behaviour and predict clinical success for pharmaceutical and biotechnology organisations.
ModernVivo
ModernVivo develops an AI platform for designing preclinical in vivo studies and finding contract research organisations for pharmaceutical, biotech and academic researchers.
Axiom Bio
This company develops artificial intelligence models that predict drug toxicity to help pharmaceutical researchers identify safety risks early in the development process.
Valohealth
This company develops an artificial intelligence platform for drug discovery and development to assist pharmaceutical partners in creating new medical treatments.
Toxometris.ai
This company provides an artificial intelligence platform for predicting chemical toxicity and drug properties for pharmaceutical and biotechnology researchers.
Formation Bio
This company develops in-licensed clinical-stage drug candidates for pharmaceutical and biotechnology partners using a proprietary artificial intelligence platform to accelerate trials.
Parallel Bio
This company develops a drug discovery platform using human immune organoids and artificial intelligence for pharmaceutical and biotechnology partners.
Known Medicine
This company develops a platform using 3D cell culture and artificial intelligence to predict drug responses for oncologists and biopharmaceutical developers.
